Chronic Kidney Disease (CKD)
Conditions
Interventions
Administration of lubiprostone to CKD patients
Sponsors
Tohoku University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: CKD patients with constipation
Exclusion criteria
Exclusion criteria: ileus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| constipation Concentration of uremic toxins Renal funcitons | — |
Secondary
| Measure | Time frame |
|---|---|
| gutmicrobiota | — |
Countries
Japan
Contacts
Public ContactTakaaki ABE
Tohoku University Graduate School of Biomedical Engineering Division of Medical Science
Outcome results
None listed